- Home
- ALZN vs SGBX Comparison
ALZN vs SGBX Comparison
Compare ALZN & SGBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- SGBX
- Stock Information
- Founded
- ALZN 2016
- SGBX 2007
- Country
- ALZN United States
- SGBX United States
- Employees
- ALZN N/A
- SGBX N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- SGBX RETAIL: Building Materials
- Sector
- ALZN Health Care
- SGBX Consumer Discretionary
- Exchange
- ALZN Nasdaq
- SGBX Nasdaq
- Market Cap
- ALZN 2.3M
- SGBX 2.7M
- IPO Year
- ALZN 2021
- SGBX 2017
- Fundamental
- Price
- ALZN $2.35
- SGBX $0.40
- Analyst Decision
- ALZN Strong Buy
- SGBX
- Analyst Count
- ALZN 1
- SGBX 0
- Target Price
- ALZN $180.00
- SGBX N/A
- AVG Volume (30 Days)
- ALZN 216.5K
- SGBX 75.4M
- Earning Date
- ALZN 09-10-2025
- SGBX 08-18-2025
- Dividend Yield
- ALZN N/A
- SGBX N/A
- EPS Growth
- ALZN N/A
- SGBX N/A
- EPS
- ALZN N/A
- SGBX N/A
- Revenue
- ALZN N/A
- SGBX $4,574,857.00
- Revenue This Year
- ALZN N/A
- SGBX $1,628.82
- Revenue Next Year
- ALZN N/A
- SGBX N/A
- P/E Ratio
- ALZN N/A
- SGBX N/A
- Revenue Growth
- ALZN N/A
- SGBX N/A
- 52 Week Low
- ALZN $2.06
- SGBX $0.18
- 52 Week High
- ALZN $135.54
- SGBX $1.92
- Technical
- Relative Strength Index (RSI)
- ALZN 35.09
- SGBX 42.92
- Support Level
- ALZN $2.14
- SGBX $0.27
- Resistance Level
- ALZN $2.44
- SGBX $0.61
- Average True Range (ATR)
- ALZN 0.17
- SGBX 0.09
- MACD
- ALZN -0.03
- SGBX -0.02
- Stochastic Oscillator
- ALZN 23.97
- SGBX 43.49
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.